(VIANEWS) – Shares of MAUNA KEA TECH (CAC 40: MKEA.PA) jumped by a staggering 19.77% to €0.72 at 11:57 EST on Friday, after two sequential sessions in a row of losses. CAC 40 is rising 0.17% to €7,551.29, following the last session’s downward trend. This seems, up to now, a somewhat up trend trading session today.
MAUNA KEA TECH’s last close was €0.60, 39.9% below its 52-week high of €0.99.
About MAUNA KEA TECH
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, MAUNA KEA TECH has a trailing twelve months EPS of €-0.27.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MAUNA KEA TECH’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for MAUNA KEA TECH is 1488239 which is 337.99% above its average volume of 339784.
More news about MAUNA KEA TECH (MKEA.PA).
